Journals / MN Kardiyoloji / 2002 / Cilt: 9 - Sayı: 4

Evaluation of the morphologic and functional changes of cardiac structures in hemodialysis patients with end stage renal disease (ESDR) by transthoracic echocardiography

Son dönem böbrek yetmezliği nedeniyle düzenli hemodiyalize giren hastalarda kalpte ortaya çıkan yapısal ve fonksiyonel değişikliklerin ekorkardiyografik olarak değerlendirilmesi

Pages
250–254
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Statisticaly significant differecences were detected when the groups were compared for IVRT and E/A ratios ( group II had prolonged IVRT and decreased E/A ratio, p=0.041, p=0.022, respectively) CONCLUSION: In conclusion, cardiac morphologic changes and pathological diastolic flow patterns were determined by echocardiography, in most of the patients with ESRD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: The aim of this study was to investigate the morphologic and functional changes of cardiac structures in hemodialysis patients with end stage renal disease (ESDR) by transthoracic echocardiography.
📊
Key Findings & Data:MATERIALS AND METHODS: Fifty-two patients with ESDR (mean age:48±13 years, 21 female 31 male) were recruited.
💡
Conclusion & Impact:Statisticaly significant differecences were detected when the groups were compared for IVRT and E/A ratios ( group II had prolonged IVRT and decreased E/A ratio, p=0.041, p=0.022, respectively) CONCLUSION: In conclusion, cardiac morphologic changes and pathological diastolic flow patterns were determined by echocardiography, in most of the patients with ESRD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Böbrek yetmezliği · Renal diyaliz · Ekokardiyografi

Abstract

AIM: The aim of this study was to investigate the morphologic and functional changes of cardiac structures in hemodialysis patients with end stage renal disease (ESDR) by transthoracic echocardiography. MATERIALS AND METHODS: Fifty-two patients with ESDR (mean age:48±13 years, 21 female 31 male) were recruited. Patients were divided into two groups according to duration of hemodialysis; 23 ESDR patients with duration shorter than 24 months (3-23), Group I and 29 ESDR patients with a duration longer than 24 months (24-96) , Group II. RESULTS: In 79% of the cases, cardiac morphologic changes were detected by two-dimensional echocardiography [Icy-glass appearance (IGA) in 75 % of the cases, left ventricular hypertrophy (LVH) in 67% of the cases, aortic valve calsification (AVC) in 56% of cases pericardial effusion (PEF) in %48 of cases, mitral annular calcification (MAC) in 32 % of cases]. Statisticaly significant differecences were detected when the groups were compared for LVH, IGA, MAC and AVC (p=0.04, p=0.038, p=0.041, p=0.033, respectively). Pathologic diastolic flow pattern was determined in 81% (40/52) of the cases by echocardiographic examination. Statisticaly significant differecences were detected when the groups were compared for IVRT and E/A ratios ( group II had prolonged IVRT and decreased E/A ratio, p=0.041, p=0.022, respectively) CONCLUSION: In conclusion, cardiac morphologic changes and pathological diastolic flow patterns were determined by echocardiography, in most of the patients with ESRD. Among the echocardiographic findings, presence of LVH, IGA, MAC, AVC, E/A and IVRT were more influenced by the duration of disease.

Özet

AMAÇ: Bu çalışmada son dönem böbrek yetersizliği (SDBY) nedeniyle düzenli hemodiyalize giren hastalarda kalpte ortaya çıkan fonksiyonel ve yapısal değişikliklerin transtorasik ekokardiyografi (TTE) ile araştırılması amaçlandı. GEREÇ VE YÖNTEM: Çalışmaya SDBY'i olan 52 hasta (ortalama yaşları:48±13 yıl, 21 kadın ve 31 erkek) alındı. Hastalar dialize girdikleri süre dikkate alınarak 2 gruba ayrıldı; diyalize girdiği süre 24 aydan kısa (3-23 ay) olan 23 hasta (1.grup), 24 aydan uzun (24-96 ay) olan 29 hasta (2.grup). BULGULAR: İki boyutlu (2-D) ekokardiyografik incelemede olguların %79'unda yapısal değişiklikler (Miyokardda buzlu cam görünümü (MBCG), 39 (%75); sol ventrikül hipertrofisi (SVH), 37 (%67); mitral anuler kalsifikasyon (MAK), 17(%32); aort kapak kalsifikasyonu (AKK), 29 (%56); perikardiyal effüzyon (PEF), 25 (%48) hastada saptandı. SVH, MBCG, MAK ve AKK yönünden iki grup arasında istastistiksel olarak anlamlı fark bulundu (sırasıyla: p=0.04, p=0.038, p=0.041, p=0.033). Doppler ekokardiyografik incelemelerinde hastaların %81'inde (40/52) patolojik diyastolik akım paterni mevcuttu (E/A oranı<1). İki grup arasında E/A oranı ve izovolümetrik gevşeme zamanı (IVGZ) yönünden anlamlı fark (II.grup uzamış IVGZ ve azalmış E/A'ya sahipti) saptandı (sırasıyla: p=0.041, p= 0.022). SONUÇ: Bu çalışmada SDBY hastalarının büyük bir kısmında kalpte yapısal değişiklikler ve patolojik diyastolik akım biçimleri saptandı. Ekokardiyografik bulgular arasında hastalığın süresinden en çok SVH, MBCG, MAK , AKK , E/A ve İVGZ etkilenmiştir.

🔖

Cite This Article

YAZICI, M., ERBİLEN, E., ÖZER, İ., ALBAYRAK, E. S., YILDIZ, İ., AKCAN, Y., UYAN, C. (2002). Evaluation of the morphologic and functional changes of cardiac structures in hemodialysis patients with end stage renal disease (ESDR) by transthoracic echocardiography. MN Kardiyoloji, Cilt: 9 - Sayı: 4, 250–254. https://ajindex.com/articles/299132

References (12)

  1. Lewey ASj Bet0 JAı parfrey ps et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know ? Where do we go from here? Am J Kidney Dis 1998; 32:85-96. US Renal Data System. Annual Data Report. National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD:1998 Parfrey PS. Cardiac disease in dialysis patients. Sem Dial 1999; 12:61-132.
  2. Huting J, Kramer W, Schutterle G, Wizemann V. Analysis of left ventricular changes associated with chronic hemodialysis. Non invasive follow-up study. Nephron 1988; 49:284-90.
  3. Parfrey PS, Harnett JD, Griffiths SM, Taylor R, Hand J, King A, Barre PE. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 1990; 55:114-20.
  4. Morris KP, Skinner JR, Wren C, Hunter S, Coulthard MG. Cardiac abnormalities in end-stage renal failure. Arch Dis Child 1993; 68:637-43.
  5. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, King A, Barre PE. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47:186- 92. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. The outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant 1996; 11:1277-85.
  6. London GM, Fabiani F. Left ventricular dysfunction in end-stage renal disease: echocardiographic insights. In Parfrey PS, Harnett JD, eds. Cardiac dysfunction in chronic uremia:pathogenesis. Kluwer Academic, Boston, MA. 1992:17-138.
  7. Huting J, Kramer W, Reittinger J, Kuhn K, Wizemann V, Schutterle G. Morphologic and functional changes occurred in cardiac structure and functionin continious ambulatory peritoneal dialysis:influence of blood purification and hypercirculation. Am Heart J 1990; 119:334- 52. Devereux RB, Roman MJ. Ultrasonic techniques for the evaluation of hypertension. Curr Opin Nephrol Hypertens 1994; 3:644-51.
  8. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol. 2000; 11:912-16.
  9. Guerin A, Marchais S, Pannier B, London G. Cardiac anomalies in chronic renal failure. Presse Med. 2000; 29:274-80.
  10. Scharer K, Schmidt KG, Soergel M. Cardiac function and structure in chronic renal failure. Pediatr Nephrol. 1999; 13:951-65.
  11. Rostand SG, Rutsky EA. Pericarditis in end-stage renal disease. Cardiol Clin. 1990; 8:701-07.
  12. Krane KN, Martinen J, Bleich S, Phils J.